Highlights in hepatocellular carcinoma
News

Highlights in hepatocellular carcinoma

Grace Li

Editorial office, Chinese Clinical Oncology, Guangzhou 510120, China

Corresponding to: Grace Li. Editorial office, Chinese Clinical Oncology, No. 82 Jiangnandadaozhong Road, Guangzhou 510120, China. Email: editor@thecco.net.

Submitted Sep 23, 2013. Accepted for publication Sep 24, 2013.

doi: 10.3978/j.issn.2304-3865.2013.09.08


We are glad to tell you that Chinese Clinical Oncology will launch a special issue on hepatocellular carcinoma (HCC) by the end of 2013, which studies HCC in different specific circumstance given due consideration. Our Guest Editor for this special issue is Prof Ghassan K. Abou-Alfa, from Memorial Sloan-Kettering Cancer Center, New York, USA.

In this special issue, known experts worldwide in related field are getting together to share their knowledge in terms of diagnosis and treatment of HCC. Apart from the up-to-date review in HCC, You will also be able to learn the status of HCC in a wide geographic background including Asia, Europe and America. We hope you will enjoy this special issue.

The outline for this special issue is as follows:

Preface

Ghassan K. Abou-Alfa/USA

Viral hepatitis and non-alcoholic fatty liver disease as risk factors for hepatocellular carcinoma

Maya Gambarin-Gelwan/USA

A review of hepatocellular carcinoma (HCC) staging systems

Somasundaram Subramaniam, Robin K. Kelley, Alan P. Venook/USA

Management of liver cirrhosis in patients with hepatocellular carcinoma.

Bahaa Eldeen Senousy Ismail, Roniel Cabrera/USA

Hepatocellular carcinoma in the modern era: transplantation, ablation, open surgery or minimally invasive surgery? A multidisciplinary personalized decision

Ioannis Constantinidis, Yuman Fong/USA

Percutaneous therapies of hepatocellular carcinomaan update

Julius Chapiro, Jean-François Henri Geschwind/USA

Systemic therapy for hepatocellular carcinoma

James Harding, Ghassan Abou-Alfa/USA

Features and treatment options of Chinese hepatocellular carcinoma

Qiong Wu, Shu-Kui Qin/China

Status of hepatocellular carcinoma in South Korea

Hoo Guen Chun/Korea

Current status of hepatocellular carcinoma in Japan

Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Takuji Okusaka/Japan

Hepatocellular carcinoma in India

G. S. Bhattacharyya, K. Govind Babu, Hemant Malhotra, A. A. Ranade, Shaiqua Murshed, Debasis Datta/India

Status of hepatocellular carcinoma in gulf region

Kakil Ibrahim Rasul/Qatar

Risk factors for developing hepatocellular carcinoma in Egypt

Ashraf Omar, Ghassan K. Abou-Alfa, Ahmed khairy/Egypt

Status of HCC in Europe

Alexa Childs, James O’Beirne, Tim Meyer/UK

Current status of hepatocellular carcinoma in the United States

Andrew Zhu/USA


Acknowledgements

Disclosure: The author declares no conflict of interest.

Cite this article as: Li G. Highlights in hepatocellular carcinoma. Chin Clin Oncol 2013;2(3):28. doi: 10.3978/j.issn.2304-3865.2013.09.08

Refbacks

  • There are currently no refbacks.